AI Science Tracker

Queen’s University

1 discovery from 2026

Discoveries

ML ranking identifies active sesquiterpene-synthase variants

A composite score combines Boltz2-predicted binding and DLKcat-predicted turnover to rank variants in a focused Agr5 library. Of 15 top-ranked variants tested, four produced more viridiflorol than wild-type Agr5; the paper reports 11.05-fold higher production for Y374F and a 952.79 mg/L titer in its yeast assay. The initial V314G design involved mechanism-guided human analysis, and the measured values are assay-specific.

Technology: DeEnzyme_score combining Boltz2 and DLKcat predictions

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: The article reports four activity-enhancing variants among 15 tested and specifies the Y374F production ratio and titer in a yeast assay.
  • Still unknown: Prior sequence-level overlap, earlier disclosure and independent replication remain unestablished; the proposed allosteric explanation partly relies on simulation.
  • AI role: Boltz2 and DLKcat predictions are combined to rank variants selected for experimental testing; the initial V314G design is attributed to mechanism-guided analysis, not AI.

Evidence sources: https://pubs.acs.org/accacs/article/16/14/13022/5114435/Customizing-Natural-Products-of-Sesquiterpene

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 16 Nov 2026. Review scope: Publisher indexed full article text including title, methods, results, article history and author-affiliation block; direct ACS endpoint returned 403..

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.